Jirapinyo, Pichamol;
Hadefi, Alia;
Thompson, Christopher C;
Patai, Árpád V;
Pannala, Rahul;
Goelder, Stefan K;
Kushnir, Vladimir;
Barthet, Marc;
Apovian, Caroline M;
Boskoski, Ivo;
Davidson, Paul;
Donatelli, Gianfranco;
Kumbhari, Vivek;
Hayee, Bu;
Esker, Janelle;
Hucl, Tomas;
Pryor, Aurora D;
Maselli, Roberta;
Schulman, Allison R;
Pattou, Francois;
Zelber-Sagi, Shira;
Bain, Paul A;
Durieux, Valérie;
Triantafyllou, Konstantinos;
Thosani, Nirav;
Huberty, Vincent;
Sullivan, Shelby.
This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) fr...
Chianelli, M;
Busetto, L;
Vettor, R;
Annibale, B;
Paoletta, A;
Papini, E;
Albanese, A;
Carabotti, M;
Casarotto, D;
De Pergola, G;
Disoteo, O E;
Grandone, I;
Medea, G;
Nisoli, E;
Raffaelli, M;
Schiff, S;
Vignati, F;
Cinquini, M;
Gonzalez-Lorenzo, M;
Fittipaldo, V A;
Minozzi, S;
Monteforte, M;
Tralongo, A C;
Novizio, R;
Persichetti, A;
Samperi, I;
Scoppola, A;
Borretta, G;
Carruba, M;
Carbonelli, M G;
De Luca, M;
Frontoni, S;
Corradini, S. G;
Muratori, F;
Attanasio, R.
This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification.
Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a g...
La presente Guía de Práctica Clínica (GPC) fue impulsada por la DNAIENT, en el marco de las políticas
que el Ministerio de Salud de la Nación lleva adelante para reducir la morbimortalidad asociada a
las enfermedades no transmisibles y sus factores de riesgo, y reemplaza a la versión precedente del...
La Sociedad Chilena de Cirugía Bariátrica y Metabólica, junto a otras sociedades científicas, lideró el proceso de adaptación de la guía de práctica clínica de obesidad en adultos para Chile, tomando como base las directrices desarrolladas para Canadá. La guía canadiense buscó, entre sus prin...
Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
Healthy eating is important for all Canadians, regardless of body size, weight or health condition. Key messages from Canada’s Food Guide for Healthy Eating can be used as a foundation for nutrition and food-related education (Figure 1). Use evidence-based nutrition resources to give your patients nutr...
Pharmacological treatments are an effective and scalable approach to treating obesity. As with any chronic disease, such as type 2 diabetes (T2DM) or hypertension, pharmacotherapy is an important pillar in the management of obesity.
The focus of obesity management should be the improvement of health para...
Primary care clinicians should initiate patient-centred conversations with their patients about overweight or obesity. The 5As of Obesity ManagementTM (Ask-Assess-Advise-Agree-Assist) approach, starting with asking permission to discuss weight, is an appropriate format to use.
Primary care clinicians sho...
Según la Organización Mundial de la Salud, la obesidad se define como una acumulación excesiva de
grasa corporal (1), que tiene una estrecha relación con la aparición o complicación de enfermedades
crónicas como la diabetes, enfermedades cardiovasculares, y el cáncer (2).
En la actualidad, la obe...
Policy makers developing obesity policies should assess and reflect on their own attitudes and beliefs related to obesity.
Public health policy makers should avoid using stigmatizing language and images. It is well established that shaming does not change behaviours. In fact, shaming can increase the lik...
